Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Eli Lilly Q2 FY24

Mounjaro, Zepbound, and Verzenio drive growth.

• Revenue +36% Y/Y to $11.3B ($1.3B beat).
• EPS $3.92 ($1.16 beat).

FY24 guidance (high end):
• Revenue +$3.0B to $46.6B.
• EPS +$0.29 to $14.00.
Credit image to: App Economy Insights
Credit image to: App Economy Insights
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
6
1
+0
Translate
Report
155K Views
Comment
Sign in to post a comment